Patient Reported Experience Measure in Endoscopic Ultrasonography: The PREUS Study Protocol

Abstract

The evaluation of the patient’s experience is becoming increasingly important as a better patient experience can improve the quality of the health service delivered. Patient-reported experience measures (PREMs) are self-report assessment tools provided to patients about their experience during any health event. There are few PREM instruments in the field of gastrointestinal endoscopy, and none is specific for endoscopic ultrasound (EUS). This study aims to develop a questionnaire to evaluate the experience of patients undergoing EUS, identifying and prioritizing the factors related to the patient’s experience. The study will consist of several phases: (A) tool creation; (B) face and content validity; (C) ranking: to evaluate the relevance of the identified questions in the previous phase; (D) questionnaire creation and validity testing. The final output will be the production of a specific tool that can be used to measure patients’ experience during EUS. This questionnaire may become a relevant part of actions taken to measure the quality of care provided to patients undergoing EUS. Furthermore, correlation between health care providers’ and patients’ views of the relevance of the included items will allow optimization of empathetic and psychological aspects.

Needs and expectations of family caregivers of cancer patients in palliative care: A study protocol

“…Similar to previously published study protocols (Apadula et al, 2022;Chen et al, 2022;Laker et al, 2022), with the development of this protocol, we seek to present the aims, methodological approach and plan to operationalize the research.…”

Nurses’ Motivations, Barriers, and Facilitators to Engage in a Peer Review Process: A Qualitative Study Protocol

“…Therefore, the publication of study protocols can help improve the medical research standard. We can identify many published study protocols in the literature, from quantitative [ 33 , 34 , 35 ] to qualitative [ 36 , 37 , 38 ] investigations to literature review protocols [ 39 , 40 , 41 ]. As in previously published study protocols, with the writing of this study protocol, we intend to present the aims, methodological approach, and plan to operationalize the research.…”

The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers

“…The most frequently used and most widely validated biomarker is CA 19–9, but, due to its low specificity and high false positive and negative rate, CA 19–9 is not sufficiently reliable as a diagnostic marker in clinical practice [ 128 ]. For this reason, some studies have focused on the combined detection of CA19-9 together with other tumor markers such as carcino-embryonic antigen (CEA), carbohydrate antigen 125 (CA125), carbohydrate antigen 242 (CA242), and on novel serum biomarkers [ 129 ], microRNAs [ 130 ] or new imaging techniques such as endoscopic retrograde cholangio pancreatography and endoscopic ultrasonography [ 131 , 132 ]. In general, panels combining CA19-9 with other novel biomarkers may represent an ideal strategy to improve the sensitivity and specificity of CA19-9 in detecting PC.…”